California Voters Ban Flavored Tobacco, and a Cigarette Maker Is Suing
MONDAY, Nov. 14, 2022 (HealthDay News) — Only one day after California voters approved allowing a state law banning flavored tobacco products to take effect, a tobacco giant has sued to prevent it.R.J. Reynolds on Wednesday filed a federal lawsuit ch…
Learn MoreCancer of the Appendix: Very Rare, But Genes May Play Role
MONDAY, Nov. 14, 2022 (HealthDay News) — While appendix cancer is rare, for a small percentage of patients the disease may be linked to a particular genetic variant, a new study suggests. Researchers built on earlier research with this study, finding…
Learn MoreBinge Eating Disorder Looks Different in Brains of Boys and Girls
MONDAY, Nov. 14, 2022 (HealthDay News) — The brains of girls and boys who have binge eating disorder show key differences, according to a new study.That’s an important finding, researchers say, because both genders struggle with eating disorders, yet…
Learn MoreShe Thought Cancer Had Won — Until This Experimental Therapy
FRIDAY, Nov. 11, 2022 (HealthDay News) — The breast cancer of author and poet Stephanie Gangi has receded and advanced in wearying waves for two decades now.First diagnosed and treated in 1999, Gangi’s cancer spread to the bone of her sternum in 2014…
Learn MoreCalifornia Voters Ban Flavored Tobacco, and a Cigarette Maker Is Suing
FRIDAY, Nov. 11, 2022 (HealthDay News) — Only one day after California voters approved allowing a state law banning flavored tobacco products to take effect, a tobacco giant has sued to prevent it. R.J. Reynolds on Wednesday filed a federal lawsuit c…
Learn More11.3 Percent of School Students Report Tobacco Product Use
THURSDAY, Nov. 10, 2022 (HealthDay News) — About 11.3 percent of all middle and high school students reported currently using any tobacco product in 2022, with electronic cigarettes the most commonly used product, according to research published in …
Learn MoreOver 3 Million U.S. School Kids Now Vaping or Smoking
THURSDAY, Nov. 10, 2022 (HealthDay News) — Despite continued efforts by health advocates and U.S. public health officials, a huge number of middle and high school students are still using addictive tobacco products, most often vaping products.A new s…
Learn MoreHealth Care Access May Affect Receipt of Therapy in Ovarian Cancer
THURSDAY, Nov. 10, 2022 (HealthDay News) — Health care access (HCA) dimensions are associated with receipt of guideline-concordant therapy, but they do not fully explain racial disparities among patients with ovarian cancer, according to a study publ…
Learn MoreNab-Paclitaxel, Pembrolizumab Combo Active in Advanced Urothelial Cancer
THURSDAY, Nov. 10, 2022 (HealthDay News) — For patients with platinum-refractory or cisplatin-ineligible advanced urothelial cancer, the combination of nab-paclitaxel and pembrolizumab is promising, according to a study published online Nov. 1 in The…
Learn MoreDoctors Use CRISPR Technology to Boost Cancer Immunotherapy
THURSDAY, Nov. 10, 2022 (HealthDay News) — Gene editing has for the first time produced modified immune cells finely honed to target and attack cancer cells, researchers say.A team used the gene editing tool CRISPR to alter immune cells drawn from 16…
Learn More